RACC compared with CATX: revenue, margins and what each company keeps, and the suppliers and customers both name

RACCResearch Alliance Corp III

Mkt capRevenueRevenue

CATXPerspective Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RACCResearch Alliance Corp III

CATXPerspective Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RACC

No earnings history for RACC.

CATX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±21.1%▲+6.00%×0.28

May 12 '26±85.0%▼−2.84%×0.03

Q1 FY26±10.4%▼−5.17%×0.50

Jan 9 '26±87.1%▲+1.07%×0.01

= impliedRACC realized, solidCATX realized, hatchedOne scale, both sides: full bar = 88%× = |realized| ÷ impliedSource: market data

RACCResearch Alliance Corp III

10.14▼−0.07%· post 10.11

Mkt cap$49.0MRevenue—Revenue—

CATXPerspective Therapeutics, Inc.

1.04▼−9.51%· post 1.04

ClosedNov 2 '26

Mkt cap$131.3MRevenue$81,000Q2 FY26Revenue$884,000FY25

Compare

ClosedNov 2 '26

RACCResearch Alliance Corp III

CATXPerspective Therapeutics, Inc.

10.14▼−0.07%post 10.11

Price

1.04▼−9.51%post 1.04

$49.0M

Mkt cap

$131.3M

—

Revenue

$81,000Q2 FY26

—

Revenue

$884,000FY25

RACC10.14▼−0.07%vsCATX1.04▼−9.51%ClosedNov 2 '26